PCAB compounding pharmacy accreditation: what the badge can—and cannot—tell you

01

PCAB is a voluntary accreditation offered by ACHC

PCAB historically refers to the Pharmacy Compounding Accreditation Board brand and is now offered through the Accreditation Commission for Health Care. A pharmacy chooses to seek accreditation and must satisfy the accreditor’s application, documentation, survey, corrective-action, and maintenance requirements for the awarded scope.

Accreditation is different from licensure. State boards of pharmacy issue and enforce pharmacy licenses under state law, while a private accreditor evaluates an organization against its program standards. ACHC itself distinguishes PCAB peer review from its state-approved Pharmacy Inspection Services.

The distinction matters when a provider says its pharmacy is “certified” or “approved.” Ask who issued the credential, under which program, for which location and service, and on what dates. A logo without those facts is a marketing lead, not completed verification.

02

Sterile, nonsterile, and hazardous-drug scopes are not interchangeable

ACHC says its PCAB nonsterile compounding accreditation references USP General Chapter <795> and evaluates process standards focused on quality and consistency for nonsterile preparations. Its sterile compounding accreditation references USP <797> and focuses on procedures intended to prevent contamination and maintain quality for sterile preparations.

ACHC describes hazardous-drug handling as an additional PCAB service incorporating USP <800> requirements. It is not a stand-alone substitute for the sterile or nonsterile scope. A pharmacy may therefore hold one service without holding every other service a consumer assumes from the PCAB name.

An injectable peptide is a sterile preparation, so a nonsterile-only accreditation would not answer the relevant scope question. Consumers should ask the accreditor or pharmacy to identify the active sterile-compounding service for the exact location rather than accepting a general statement that the company is PCAB accredited.

03

PCAB and NABP accreditation are different programs

The National Association of Boards of Pharmacy offers a separate Compounding Pharmacy Accreditation. NABP says its program addresses alignment with USP <795>, <797>, and <800> as applicable and is available to eligible U.S.-licensed pharmacies that actively compound.

NABP describes its accreditation as a three-year term with annual compliance reviews in years two and three. Its process includes a Verified Pharmacy Program inspection before an organization can complete the accreditation application. Those details belong to NABP’s program and should not be attributed to PCAB without support.

A pharmacy can name one program, the other, both, or neither. Do not combine badges into a vague claim that a pharmacy is nationally approved. Verify each credential with its issuing organization and record the program name, scope, location, status, and review date.

04

What accreditation cannot establish about a peptide product

FDA states that compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or quality. Private accreditation does not change that status. It also does not turn a compounded preparation into an approved generic or make an unapproved active ingredient lawful.

A facility-level credential cannot prove that a specific lot contains the labeled ingredient or concentration, remained sterile, was stored correctly, or is suitable for a particular person. Those questions require product and patient-specific evidence, including the label, lot, compounding record, ingredient pathway, applicable testing, dispensing record, and clinical evaluation.

Accreditation also is not a permanent guarantee. Credentials have dates and scopes; organizations can change ownership, location, services, personnel, or status. State-board actions, FDA inspections, recalls, warning letters, and complaints are separate records that should be checked independently.

05

A practical accreditation verification workflow

Begin with the pharmacy’s legal name and physical address as printed on the prescription label. Brand names, telehealth program names, and fulfillment partners may differ from the licensed compounder. Match the credential to the entity and location that actually prepared the product.

Ask for the issuing accreditor, program, service scope, effective date, and expiration or renewal date. NABP provides a request form for checking the status of its Compounding Pharmacy Accreditation. For PCAB, use ACHC’s accredited-organization channel or contact ACHC and preserve the result. Do not rely only on a footer logo or an undated certificate image.

Then check the state board of pharmacy for the home-state license and any nonresident authority relevant to the patient’s location. If the facility claims 503B outsourcing status, verify the exact address in FDA’s registry. Accreditation, licensure, and 503B registration answer different questions, and none should be used as a substitute for another.

• →Legal pharmacy name and exact compounding location
• →Issuing accreditor and program name
• →Sterile or nonsterile scope
• →Active and expiration dates
• →Home and nonresident state licenses
• →503A or 503B pathway and separate FDA records

06

How to interpret accreditation in provider comparisons

A current, relevant accreditation can be recorded as a positive transparency and process signal. It shows that a pharmacy sought outside review against a defined program. It should not be converted into a clinical ranking, a treatment endorsement, or a claim that an accredited pharmacy is always safer than every unaccredited pharmacy.

Compare the credential with other evidence: pharmacy licenses, responsible pharmacist, provider disclosure, product label, recall history, FDA inspection or enforcement records when applicable, adverse-event process, and the reason a compounded drug is being considered. A provider that names an accredited pharmacy but ships from another entity has not answered the question.

Ask the clinician and pharmacist about the exact product and individual need. A directory can document a badge and its scope, but it cannot certify quality for a lot, diagnose a problem, or recommend treatment. Suspected product-quality problems should be raised with the responsible professionals and reported through appropriate regulator channels.